NDMA In Ranitidine Risks Rerun Of Sartans Crisis

 
• By Dave Wallace

Regulators in North America and Europe are reacting to the discovery of the impurity NMDA in ranitidine, just over a year after similar impurities in sartan products led to a slew of recalls and withdrawals around the world.

Nitrosodimethylamine
Canadian, European and US regulators are evaluating the discovery of NDMA in ranitidine • Source: Shutterstock

More from Generics

More from Products